Cargando…

Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies

Fatigue is one of the most common symptoms associated with cancer. Persistent fatigue can impair multiple aspects of daily functioning and quality of life, and patients report that treatment-related fatigue has a greater impact than other symptoms, including pain, nausea, and depression. Thus, manag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larkin, James M.G., Pyle, Lynda M., Gore, Martin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2010
Materias:	Academia–Pharma Intersect
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227914/ https://www.ncbi.nlm.nih.gov/pubmed/21051659 http://dx.doi.org/10.1634/theoncologist.2010-0078

Ejemplares similares

Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review
por: Agarwala, Sanjiv S., et al.
Publicado: (2010)

Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
por: Boccia, Ralph, et al.
Publicado: (2022)

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
por: Garbe, Claus, et al.
Publicado: (2011)

Targeting CDK4 and 6 in Cancer Therapy: Emerging Preclinical Insights Related to Abemaciclib
por: Wander, Seth A, et al.
Publicado: (2022)

Castration-Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment
por: Aggarwal, Rahul, et al.
Publicado: (2011)

Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
por: Ludwig, Heinz, et al.
Publicado: (2010)

Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents
por: Moxley, Katherine M., et al.
Publicado: (2010)

Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery
por: Tejpar, Sabine, et al.
Publicado: (2010)

Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review
por: Rosen, Lee S., et al.
Publicado: (2010)

Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
por: Scagliotti, Giorgio, et al.
Publicado: (2010)

Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer
por: Thatcher, Nicholas, et al.
Publicado: (2010)

Lapatinib plus Letrozole as First-Line Therapy for HER-2(+) Hormone Receptor–Positive Metastatic Breast Cancer
por: Schwartzberg, Lee S., et al.
Publicado: (2010)

Quality of Life in Hormone Receptor–Positive HER-2(+) Metastatic Breast Cancer Patients During Treatment with Letrozole Alone or in Combination with Lapatinib
por: Sherrill, Beth, et al.
Publicado: (2010)

Effect of Patient Age on Management Decisions in Breast Cancer: Consensus from a National Consultation
por: Leonard, Robert C., et al.
Publicado: (2010)

Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US
por: Vachhani, Pankit, et al.
Publicado: (2022)

Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
por: Wang, Tzu-Fei, et al.
Publicado: (2023)

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010)

Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study
por: Extra, Jean-Marc, et al.
Publicado: (2010)

Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
por: Cameron, David, et al.
Publicado: (2010)

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial
por: Pronzato, Paolo, et al.
Publicado: (2010)

The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab
por: Castellano, Daniel, et al.
Publicado: (2011)

Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)
por: Popat, Sanjay, et al.
Publicado: (2022)

Targeting BRAF‐Mutant Non‐Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy
por: Baik, Christina S., et al.
Publicado: (2017)

Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents
por: Cheson, Bruce D., et al.
Publicado: (2017)

Hormone Receptor–Positive/Human Epidermal Growth Receptor 2–Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents
por: Shah, Ami N., et al.
Publicado: (2020)

Intratumoral Immunotherapy—Update 2019
por: Hamid, Omid, et al.
Publicado: (2019)

What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions
por: Gambardella, Jessica, et al.
Publicado: (2020)

News
Publicado: (2023)

Laughter therapy: A humor-induced hormonal intervention to reduce stress and anxiety
por: Akimbekov, Nuraly S., et al.
Publicado: (2021)

Getting everyone to the table: exploring everyday and everynight work to consider ‘latent social threats’ through interprofessional tabletop simulation
por: Brydges, Ryan, et al.
Publicado: (2021)

Female excellence in rock climbing likely has an evolutionary origin
por: Carroll, Collin
Publicado: (2021)

High-fat diet-associated cognitive decline: Is zinc finger protein 1 (ZPR1) the molecular connection?
por: Chittilla, Mythri, et al.
Publicado: (2021)

Critical design choices in healthcare simulation education: a 4C/ID perspective on design that leads to transfer
por: Frerejean, Jimmy, et al.
Publicado: (2023)

Data-driven resuscitation training using pose estimation
por: Weiss, Kerrin E., et al.
Publicado: (2023)

Measuring cognitively demanding activities in pediatric out-of-hospital cardiac arrest
por: Bahr, Nathan, et al.
Publicado: (2023)

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies
por: Gore, M E, et al.
Publicado: (2011)

Public Welfare Agenda or Corporate Research Agenda?
por: Singh, Ajai, et al.
Publicado: (2005)

The Connection Between Academia and Industry
por: Singh, Ajai, et al.
Publicado: (2005)

Disseminated intravascular coagulation and its immune mechanisms
por: Popescu, Narcis I., et al.
Publicado: (2022)

Renal cell carcinoma and the use of sorafenib
por: Larkin, James MG, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ebia51hkfucpltefroifi6bsmh